These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 20211062)

  • 1. [CD44 variant increases the invasive ability of human breast cancer cell line MCF-7 cells].
    Fang XJ; Xu WL; Gong JL; Chen C; Fang LL; Chen QY
    Zhonghua Zhong Liu Za Zhi; 2010 Jan; 32(1):22-8. PubMed ID: 20211062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of a new CD44st in increasing the invasion capability of the human breast cancer cell line MCF-7.
    Fang XJ; Jiang H; Zhao XP; Jiang WM
    BMC Cancer; 2011 Jul; 11():290. PubMed ID: 21749678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. (-)-Epigallocatechin-3-gallate down-regulates EGFR, MMP-2, MMP-9 and EMMPRIN and inhibits the invasion of MCF-7 tamoxifen-resistant cells.
    Farabegoli F; Papi A; Orlandi M
    Biosci Rep; 2011 Apr; 31(2):99-108. PubMed ID: 20446926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Doxorubicin induces drug resistance and expression of the novel CD44st via NF-κB in human breast cancer MCF-7 cells.
    Fang XJ; Jiang H; Zhu YQ; Zhang LY; Fan QH; Tian Y
    Oncol Rep; 2014 Jun; 31(6):2735-42. PubMed ID: 24715151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced membrane-type 1 matrix metalloproteinase expression by hyaluronan oligosaccharides in breast cancer cells facilitates CD44 cleavage and tumor cell migration.
    Kung CI; Chen CY; Yang CC; Lin CY; Chen TH; Wang HS
    Oncol Rep; 2012 Nov; 28(5):1808-14. PubMed ID: 22922740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Relationship between LKB1 gene and invasion-related factors of breast cancer cells].
    Zhuang ZG; Di GH; Hou YF; Liu G; Luo JM; Shen ZZ; Shao ZM
    Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(2):81-4. PubMed ID: 17418010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased invasion and expression of MMP-9 in human colorectal cell lines by a CD44-dependent mechanism.
    Murray D; Morrin M; McDonnell S
    Anticancer Res; 2004; 24(2A):489-94. PubMed ID: 15152948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A splice variant of CD99 increases motility and MMP-9 expression of human breast cancer cells through the AKT-, ERK-, and JNK-dependent AP-1 activation signaling pathways.
    Byun HJ; Hong IK; Kim E; Jin YJ; Jeoung DI; Hahn JH; Kim YM; Park SH; Lee H
    J Biol Chem; 2006 Nov; 281(46):34833-47. PubMed ID: 16984917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stable knockdown of clusterin by vectorbased RNA interference in a human breast cancer cell line inhibits tumour cell invasion and metastasis.
    Li J; Jia L; Zhao P; Jiang Y; Zhong S; Chen D
    J Int Med Res; 2012; 40(2):545-55. PubMed ID: 22613415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Inhibitory effect of MT1-MMP antisense nucleotide on invasion of human highly metastatic ovarian cancer cell line SW626].
    Wu MF; Liao GN; Jia P; Xi L; Lu YP; Ma D
    Ai Zheng; 2004 Nov; 23(11):1263-6. PubMed ID: 15522170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Role of matrix metalloproteinase (MMP)-2 and -9 and vascular endothelial growth factor C in lymph node metastasis of breast cancer].
    Zheng SQ; Huang RQ; Zhang YJ
    Zhonghua Bing Li Xue Za Zhi; 2010 Apr; 39(4):240-4. PubMed ID: 20654122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ShRNA-mediated gene silencing of MTA1 influenced on protein expression of ER alpha, MMP-9, CyclinD1 and invasiveness, proliferation in breast cancer cell lines MDA-MB-231 and MCF-7 in vitro.
    Jiang Q; Zhang H; Zhang P
    J Exp Clin Cancer Res; 2011 May; 30(1):60. PubMed ID: 21595884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Inhibition of NF-kappaB through IkappaBalpha transfection affects invasion of human lung cancer cell line A549].
    Zhang J; Xu YJ; Xiong WN; Zhang ZX; DU CL; Qiao LF; Ni W; Chen SX
    Ai Zheng; 2008 Jul; 27(7):710-5. PubMed ID: 18606063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EGFR inhibition by (-)-epigallocatechin-3-gallate and IIF treatments reduces breast cancer cell invasion.
    Farabegoli F; Govoni M; Spisni E; Papi A
    Biosci Rep; 2017 Jun; 37(3):. PubMed ID: 28465354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kalopanaxsaponin A inhibits PMA-induced invasion by reducing matrix metalloproteinase-9 via PI3K/Akt- and PKCdelta-mediated signaling in MCF-7 human breast cancer cells.
    Park SK; Hwang YS; Park KK; Park HJ; Seo JY; Chung WY
    Carcinogenesis; 2009 Jul; 30(7):1225-33. PubMed ID: 19420016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyaluronan-CD44s signaling regulates matrix metalloproteinase-2 secretion in a human lung carcinoma cell line QG90.
    Zhang Y; Thant AA; Machida K; Ichigotani Y; Naito Y; Hiraiwa Y; Senga T; Sohara Y; Matsuda S; Hamaguchi M
    Cancer Res; 2002 Jul; 62(14):3962-5. PubMed ID: 12124327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyul-Tong-Ryung suppresses PMA-induced MMP-9 expression by inhibiting AP-1-mediated gene expression via ERK 1/2 signaling pathway in MCF-7 human breast cancer cells.
    Kim KS; Yao L; Lee YC; Chung E; Kim KM; Kwak YJ; Kim SJ; Cui Z; Lee JH
    Immunopharmacol Immunotoxicol; 2010 Dec; 32(4):600-6. PubMed ID: 20131957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Relationship between raf kinase inhibitor protein and metastasis of ovarian carcinoma].
    Wang Y; Yang J; Gao Y; Zhao XL; Li HZ; Yao Z
    Zhonghua Fu Chan Ke Za Zhi; 2009 Jul; 44(7):522-8. PubMed ID: 19957553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [FAK related non-kinase (FRNK) inhibits migration of a human breast carcinoma cell line MDA-MB-435].
    Qin J; Liu ZX
    Ai Zheng; 2006 Jul; 25(7):833-8. PubMed ID: 16831273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrilysin over-expression in MCF-7 cells enhances cellular invasiveness and pro-gelatinase activation.
    Wang F; Reierstad S; Fishman DA
    Cancer Lett; 2006 May; 236(2):292-301. PubMed ID: 16019136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.